Inventor · disambiguated record
Alexey Ryazanov
Also filed as: RYAZANOV ALEXEY · RYAZANOV ALEXEY G
8 granted patents·11 pending applications·16 citations·filing 1997–2023
81Inventor score
Files withUNIV NEW JERSEY MED9LONGEVICA THERAPEUTICS INC5ROSSCREENING INC2PRINCETON INST OF LIFE SCIENCES1RYAZANOV ALEXEY G1
Top patents by PatentIndex Score
19 records- 0180US8916379B2Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereofRYAZANOV ALEXEY G·Filed 2010·Granted Dec 23, 2014·4 cites·4 claims
- 0267US8349576B2eEF2K assays for identifying compounds that inhibit eEF2K activityUNIV NEW JERSEY MED·Filed 2010·Granted Jan 8, 2013·1 cites·9 claims
- 0367US7087427B2Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereofUNIV NEW JERSEY MED·Filed 2001·Granted Aug 8, 2006·1 cites·7 claims
- 0463US2024024353A1Methods and compositions for extending lifespanLONGEVICA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0562US8030286B2Methods and means for increasing resistance to cell damageUNIV NEW JERSEY MED·Filed 2006·Granted Oct 4, 2011·1 cites·7 claims
- 0662US2011183942A1Methods and Compositions for Treating Alzheimer's DiseaseUNIV NEW JERSEY MED·Filed 2009·Application pending·0 cites
- 0760US7785878B2Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereofUNIV NEW JERSEY MED·Filed 2006·Granted Aug 31, 2010·0 cites·6 claims
- 0855US8604163B2EEF2K assays for identifying compounds that inhibit EEF2K activityUNIV NEW JERSEY MED·Filed 2013·Granted Dec 10, 2013·0 cites·1 claims
- 0952US2021283173A1Methods and compositions for extending lifespanLONGEVICA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1050US10653715B2Methods and compositions for extending lifespanLONGEVICA THERAPEUTICS INC·Filed 2017·Granted May 19, 2020·0 cites·11 claims
- 1148US6346406B1Elongation factor-2 kinase (EF-2 kinase), and methods of use thereforUNIV NEW JERSEY MED·Filed 1997·Granted Feb 12, 2002·9 cites·17 claims
- 1248US2020254006A1Methods and compositions for extending lifespanLONGEVICA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1345US2013041009A1Methods and means for increasing resistance to cell damageUNIV NEW JERSEY MED·Filed 2011·Application pending·0 cites
- 1444US2014378424A1Estrogen receptor modulators for reducing body weightROSSCREENING INC·Filed 2012·Application pending·0 cites
- 1542US2002142429A1Elongation factor-2 kinase (EF-2 kinase) and methods of use thereforUNIV MEDICINE AND DENTISTRY·Filed 2001·Application pending·0 cites
- 1641US2009163578A1Novel modification of immunomodulatory proteinUNIV NEW JERSEY MED·Filed 2005·Application pending·0 cites
- 1738US2016271143A1Estrogen receptor modulators for reducing body weightROSSCREENING INC·Filed 2015·Application pending·0 cites
- 1833US2015204890A1Microarrays of g protein coupled receptorsPRINCETON INST OF LIFE SCIENCES·Filed 2013·Application pending·0 cites
- 1922US2018256617A1Methods for extending lifespan and methods of screening known pharmacological agents for new usesLONGEVICA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexey Ryazanov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →